IOVA R&D Expenses
Iovance Biotherapeutics Inc · R&D Expenses
IOVA R&D Expenses
Latest reported$58.85Mperiod ending
IOVA Quarterly R&D Expenses ($0.00 → $58.85M)
Quarterly R&D Expenses
High-resolution chart · PNG
IOVA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 58,851,000 | |
| 62,487,000 | |
| 71,203,000 | |
| 75,174,000 | |
| 77,928,000 | |
| 75,965,000 | |
| 72,224,000 | |
| 68,245,000 | |
| 62,084,000 | |
| 79,783,000 | |
| 87,470,000 | |
| 87,526,000 | |
| 86,347,000 | |
| 82,734,000 | |
| 80,573,000 | |
| 72,502,000 | |
| 73,406,000 | |
| 68,300,000 | |
| 75,616,000 | |
| 65,355,000 | |
| 62,119,000 | |
| 55,949,000 | |
| 52,451,000 | |
| 43,050,000 | |
| 49,274,000 | |
| 56,952,000 | |
| 54,238,000 | |
| 41,582,000 | |
| 39,298,000 | |
| 30,905,000 | |
| 27,418,000 | |
| 27,947,000 | |
| 24,551,000 | |
| 19,912,000 | |
| 20,696,000 | |
| 17,753,000 | |
| 19,653,000 | |
| 16,623,000 | |
| 9,741,000 | |
| 8,481,000 | |
| 4,463,000 | |
| 4,192,000 | |
| 4,420,000 | |
| 4,983,000 | |
| 4,056,000 | |
| 2,011,000 | |
| 1,687,000 | |
| 353,879 | |
| 493,994 | |
| 302,662 | |
| 559,367 | |
| 250,000 | |
| 250,000 | |
| 270,000 | |
| 250,000 | |
| 250,000 | |
| 270,000 | |
| 886,000 | |
| 1,756,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 11,000 | |
| 0 |